Journal
AUTOPHAGY
Volume 17, Issue 5, Pages 1193-1204Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2020.1752979
Keywords
Autophagy; experimental autoimmune encephalomyelitis; VPS34; T cell differentiation; T cell metabolism
Categories
Funding
- NIH [DK104817, AI139046, CA177681, CA95004, T32HL069765, T32AR059039]
- Department of Defense [W81XWH-15-1-0543]
- National Multiple Sclerosis Society [60006625]
- VA Merit Award [5101BX000134]
- VA Research Career Scientist Award
Ask authors/readers for more resources
PIK3C3 plays a critical role in T cell metabolism and function, with its deficiency leading to impaired metabolism and differentiation of T cells, as well as reduced levels of active mitochondria. Interestingly, Pik3c3 deletion did not significantly affect the ability of animals to clear tumor metastases.
The PIK3C3/VPS34 subunit of the class III phosphatidylinositol 3-kinase (PtdIns3K) complex is a key early player in macroautophagy/autophagy. In this study, we assessed the contribution of PIK3C3 to T cell metabolism and function. We found that Pik3c3-deficient T cells exhibited impaired cellular metabolism, and Pik3c3-deficient CD4(+) T cells failed to differentiate into T helper 1 cells. These alterations were associated with reduced levels of active mitochondria upon T cell activation. In addition, conditional Pik3c3-deficient animals failed to mount autoreactive T cell responses and were resistant to experimental autoimmune encephalomyelitis (EAE). Interestingly, the deletion of Pik3c3 had little effect on the capacity of animals to clear tumor metastases. Collectively, our studies have revealed a critical role of PIK3C3 in T cell metabolism and the pathogenicity of these cells during EAE. Our findings also have important implications for the development of immunotherapies to treat multiple sclerosis and other inflammatory diseases by targeting PIK3C3.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available